# Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

> **NCT06367673** · PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 24 (estimated)

## Conditions studied

- AML, Adult

## Interventions

- **BIOLOGICAL:** iPSC-NK cells

## Key facts

- **NCT ID:** NCT06367673
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-30
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367673, "Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06367673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*